These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9556129)

  • 1. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.
    Hurley MM; Lee SK; Raisz LG; Bernecker P; Lorenzo J
    Bone; 1998 Apr; 22(4):309-16. PubMed ID: 9556129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study.
    Galvin RJ; Bryan P; Venugopalan M; Smith DP; Thomas JE
    Bone; 1998 Sep; 23(3):233-40. PubMed ID: 9737345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic fibroblast growth factor inhibits osteoclast-like cell formation.
    Jimi E; Shuto T; Ikebe T; Jingushi S; Hirata M; Koga T
    J Cell Physiol; 1996 Aug; 168(2):395-402. PubMed ID: 8707875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis.
    Grcević D; Lee SK; Marusić A; Lorenzo JA
    J Immunol; 2000 Oct; 165(8):4231-8. PubMed ID: 11035056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of continuous calcitonin treatment on osteoclast-like cell development and calcitonin receptor expression in mouse bone marrow cultures.
    Ikegame M; Rakopoulos M; Martin TJ; Moseley JM; Findlay DM
    J Bone Miner Res; 1996 Apr; 11(4):456-65. PubMed ID: 8992876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor.
    Oba Y; Chung HY; Choi SJ; Roodman GD
    J Bone Miner Res; 2003 Jul; 18(7):1332-41. PubMed ID: 12854845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
    Lee SK; Goldring SR; Lorenzo JA
    Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired osteoclast formation in bone marrow cultures of Fgf2 null mice in response to parathyroid hormone.
    Okada Y; Montero A; Zhang X; Sobue T; Lorenzo J; Doetschman T; Coffin JD; Hurley MM
    J Biol Chem; 2003 Jun; 278(23):21258-66. PubMed ID: 12665515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures.
    Schiller C; Gruber R; Ho GM; Redlich K; Gober HJ; Katzgraber F; Willheim M; Hoffmann O; Pietschmann P; Peterlik M
    Bone; 1998 Apr; 22(4):341-6. PubMed ID: 9556133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SC-19220, a prostaglandin E2 antagonist, inhibits osteoclast formation by 1,25-dihydroxyvitamin D3 in cell cultures.
    Inoue H; Tsujisawa T; Fukuizumi T; Kawagishi S; Uchiyama C
    J Endocrinol; 1999 May; 161(2):231-6. PubMed ID: 10320820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
    Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
    Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 17Beta-estradiol antagonizes effects of 1alpha,25-dihydroxyvitamin D3 on interleukin-6 production and osteoclast-like cell formation in mouse bone marrow primary cultures.
    Schiller C; Gruber R; Redlich K; Ho GM; Katzgraber F; Willheim M; Pietschmann P; Peterlik M
    Endocrinology; 1997 Nov; 138(11):4567-71. PubMed ID: 9348179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor.
    Kotev-Emeth S; Savion N; Pri-chen S; Pitaru S
    Bone; 2000 Dec; 27(6):777-83. PubMed ID: 11113388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture.
    Biskobing DM; Fan X; Rubin J
    J Bone Miner Res; 1995 Jul; 10(7):1025-32. PubMed ID: 7484277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of osteoclast-like cell formation by Pasteurella multocida toxin from hemopoietic progenitor cells in mouse bone marrow cultures.
    Jutras I; Martineau-Doizé B
    Can J Vet Res; 1996 Jan; 60(1):34-9. PubMed ID: 8825991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese hamster ovary cells expressing alpha4beta1 integrin stimulate osteoclast formation in vitro.
    Akatsu T; Ono K; Murakami T; Katayama Y; Nishikawa M; Wada S; Yamamoto M; Kugai N; Matsuura N; Takada Y; Nagata N
    J Bone Miner Res; 1998 Aug; 13(8):1251-9. PubMed ID: 9718193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption.
    Choi SJ; Reddy SV; Devlin RD; Menaa C; Chung H; Boyce BF; Roodman GD
    J Biol Chem; 1999 Sep; 274(39):27747-53. PubMed ID: 10488118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures.
    Romas E; Udagawa N; Zhou H; Tamura T; Saito M; Taga T; Hilton DJ; Suda T; Ng KW; Martin TJ
    J Exp Med; 1996 Jun; 183(6):2581-91. PubMed ID: 8676079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1.
    Garcia-Palacios V; Chung HY; Choi SJ; Sarmasik A; Kurihara N; Lee JW; Galson DL; Collins R; Roodman GD
    Bone; 2007 Feb; 40(2):316-22. PubMed ID: 16996813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.